Monensin potentiates lead chelation efficacy of MiADMSA in rat brain post chronic lead exposure

Food and Chemical Toxicology

Volumn 50, Issue 12, 2012, Pages 4449-4460

  Pachauri, Vidhu ^a   Dubey, Mohit ^a   Yadav, Abhishek ^a   Kushwaha, Pramod ^a   Flora, S J S ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

Chelation; Ionophore; Lead toxicity; MiADMSA; Oxidative stress

Indexed keywords

CATALASE; CHELATING AGENT; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; LEAD; MONENSIN; MONOISOAMYL 2,3 DIMERCAPTOSUCCINIC ACID; PORPHOBILINOGEN SYNTHASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; BRAIN; BRAIN TOXICITY; CHELATION; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; LEAD POISONING; LONG TERM EXPOSURE; MALE; MONOTHERAPY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; BRAIN; CHELATING AGENTS; DNA DAMAGE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; KIDNEY; LEAD; MALE; MONENSIN; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUCCIMER; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS;

EID: 84867002890     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.08.059     Document Type: Article

References (50)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Andersen O. Chemical and biological considerations in the treatment of metal intoxications by chelating agents. Mini Rev. Med. Chem. 2004, 4:11-21.
3. Bannister J.V., Bannister W.H., Rotilio G. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit. Rev. Biochem. 1987, 22:111-180.
4. Barbosa F., Tanus-Santos J.E., Gerlach R.F., Parsons P.J. A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ. Health Perspect. 2005, 113:1669-1674.
5. Berlin A., Schaller K.H. European standardized method for the determination of δ-aminolevulinic acid dehydratase activity in blood. Z. Klin. Chem. Klin. Biochem. 1974, 12:389-390.
6. Blanusa M., Varnai V.M., Piasek M., Kostial K. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr. Med. Chem. 2005, 12:2771-2794.
7. Chen K.H., Lin J.L., Lin-Tan D.T., Hsu H.H., Hsu C.W., Hsu K.H., Yen T.H. Effect of chelation therapy on progressive diabetic nephropathy in patients with type 2 diabetes and high-normal body lead burdens. Am. J. Kidney Dis. 2012, 60:530-538.
8. Corpas I., Benito M.J., Marquina D., Castillo M., Lopez N., Antonio M.T. Gestational and lactational lead intoxication produces alterations in the hepatic system of rat pups. Ecotoxicol. Environ. Safety 2002, 51:35-43.
9. Crinnion W.J. EDTA redistribution of lead and cadmium into the soft tissues in a human with a high lead burden - should DMSA always be used to follow EDTA in such cases?. Altern. Med. Rev. 2011, 16:109-112.
10. Durand F., Bernuau J., Giostra E., Mentha G., Shouval D., Degott C., Benhamou J.P., Valla D. Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut 2001, 48:849-852.
11. Dwivedi N., Mehta A., Yadav A., Binukumar B.K., Gill K.D., Flora S.J.S. MiADMSA reverses impaired mitochondrial energy metabolism and neuronal apoptotic cell death after arsenic exposure in rats. Toxicol. Appl. Pharmacol. 2011, 256:241-248.
12. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
13. FDA Medical Bulletin, 1991. Succimer approved for severe lead poisoning, 21 (Pt. 1), 5.
14. Flohe L. Changing paradigms in thiology from antioxidant defense toward redox regulation. Methods Enzymol. 2010, 473:1-39.
15. Flohe L., Gunzler W.A. Assays of glutathione-peroxidase. Methods Enzymol. 1984, 105:114-121.
16. Flora S.J.S. Arsenic-induced oxidative stress and its reversibility. Free Radic. Biol. Med. 2011, 51:257-281.
17. Flora S.J.S., Pachauri V. Chelation in metal intoxication. Int. J. Environ. Res. Public Health 2010, 7:2745-2788.
18. Flora S.J.S., Bhattacharya R., Vijayaraghavan R. Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium Edetate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fund. Appl. Toxicol. (Toxicol. Sci.) 1995, 25:233-240.
19. Flora S.J.S., Dubey R., Kannan G.M., Chauhan R.S., Pant B.P., Jaiswal D.K. Meso 2,3-dimercaptosuccinic acid (DMSA) and monoisoamyl DMSA effect on gallium arsenide induced pathological liver injury in rats. Toxicol. Lett. 2002, 132:9-17.
20. Flora S.J.S., Pande M., Mehta A. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem. Biol. Interact. 2003, 145:267-280.
21. Flora S.J.S., Saxena G., Gautam P., Kaur P., Gill K.D. Response of lead-induced oxidative stress and alterations in biogenic amines in different rat brain regions to combined administration of DMSA and MiADMSA. Chem. Biol. Interact. 2007, 170:209-220.
22. 2+. J. Pharmacol. Exp. Ther. 2007, 322:108-116.
23. Foglieni C., Fulgenzi A., Ticozzi P., Pellegatta F., Sciorati C., Belloni D., Ferrero E., Ferrero M.E. Protective effect of EDTA preadministration on renal ischemia. BMC Nephrol. 2006, 7:5.
24. Godwin H.A. The biological chemistry of lead. Curr. Opin. Chem. Biol. 2001, 5:223-227.
25. Greenwald R.A. Superoxide dismutase and catalase as therapeutic agents for human diseases. A critical review. Free Radic. Biol. Med. 1990, 8:201-209.
26. Gurer-Orhan H., Sabir H.U., Ozgüneş H. Correlation between clinical indicators of lead poisoning and oxidative stress parameters in controls and lead-exposed workers. Toxicology 2004, 195:147-154.
27. Habig W.H., Pabst M.J., Jakoby W.D. Glutathione transferase, the first enzymatic step in mecapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
28. Hamidinia S.A., Erdahl W.L., Chapman C.J., Steinbaugh G.E., Taylor R.W., Pfeiffer D.R. Monensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats. Environ. Health Perspect. 2006, 114:484-493.
29. 2+ Intoxication. J. Biol. Chem. 2002, 41:38111-38120.
30. Hissin P.J., Hilf R.A. Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
31. Jollow D.J., Mitchell J.R., Zamppaglione Z., Gillette J.R. Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolites. Pharmacology 1974, 11:151-157.
32. Jones D.P. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002, 348:93-112.
33. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of Superoxide dismutase. Indian J. Biochem. Biophys. 1984, 21:130-132.
34. Kalia K., Flora S.J.S. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J. Occup. Health 2005, 47:1-21.
35. Kannan G.M., Tripathi N., Dube S.N., Gupta M., Flora S.J.S. Toxic effects of arsenic (III) on some hematopoietic and central nervous system variables in rats and guinea pigs. Clin. Toxicol. 2001, 39:675-682.
36. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
37. Mehta A., Shaha C. Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity. J. Biol. Chem. 2004, 279:11798-11813.
38. Ohkawa H., Onishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
39. Oktem F., Arslan M.K., Dundarm B., Delibas N., Gultepe M., Ergurhan Ilhan I. Renal effects and erythrocyte oxidative stress in long-term low-level lead-exposed adolescent workers in auto repair workshops. Arch. Toxicol. 2004, 78:681-687.
40. Pachauri V., Saxena G., Mehta A., Mishra D., Flora S.J.S. Combinational chelation therapy abrogates lead-induced neurodegeneration in rats. Toxicol. Appl. Pharmacol. 2009, 240:255-264.
41. Pande M., Flora S.J.S. Lead induced oxidative damage and its response to combined administration of α-lipoic acid and succimers in rats. Toxicology 2002, 177:187-196.
42. Prasanthi R.P., Devi C.B., Basha D.C., Reddy N.S., Reddy G.R. Calcium and zinc supplementation protects lead (Pb)-induced perturbations in antioxidant enzymes and lipid peroxidation in developing mouse brain. Int. J. Dev. Neurosci. 2010, 28:161-167.
43. Sanders T., Liu Y., Buchner V., Tchounwou P.B. Neurotoxic effects and biomarkers of lead exposure: a review. Rev. Environ. Health 2009, 24:15-45.
44. Saxena G., Flora S.J.S. Lead induced oxidative stress and hematological alterations and their response to combined administration of calcium disodium EDTA with a thiol chelator in rats. J. Biochem. Mol. Toxicol. 2004, 18:221-233.
45. Socci D.J., Bjugstad K.B., Jones H.C., Pattisapu J.V., Arendash G.W. Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp. Neurol. 1999, 155:109-117.
46. Steck T.L., Kant J.A. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol. 1974, 31(Pt. A):172-180.
47. Tong S., Schirnding Y.E., Prapamontol T. Environmental lead exposure: a public health problem of global dimensions. Bull. World Health Organ. 2000, 78:1068-1077.
48. Vercesi A.E., Kowaltowski A.J., Grijalba M.T., Meinicke A.R., Castilho R.F. The role of reactive oxygen species in mitochondrial permeability transition. Biosci. Rep. 1997, 17:1.
49. Ye X.B., Fu H., Zhu J.L., Ni W.M., Lu Y.W., Kuang X.Y., Yang S.L., Shu B.X. A study on oxidative stress in lead-exposed workers. J. Toxicol. Environ. Health 1999, A57:161-172.
50. Yorifuji T., Debes F., Weihe P., Grandjean P. Prenatal exposure to lead and cognitive deficit in 7- and 14-year-old children in the presence of concomitant exposure to similar molar concentration of methyl mercury. Neurotoxicol. Teratol. 2011, 33:205-211.